A Phase 2b Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat.
Clinical trial NCT06005441 · COMPLETED
Trial details
- NCT number
- NCT06005441
- Sponsor
- Caliway Biopharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-10
- Primary completion
- 2024-10-18
- Enrollment
- 173
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.